Abstract
Recently, the author read an article published in the medical journal of Cardiovascular Diabetologist on July 4, 2020, and selected the following excerpt: “Although Glycemic variability (GV) remains yet no consensus, accumulating evidence has suggested that GV, representing either short-term (with-day and between-day variability) or long-term GV, was associated with an increased risk of diabetic macro-vascular and microvascular complications, hypoglycemia, mortality rates and other adverse clinical outcomes.” The author has selected a few excepts from other research papers regarding the subject of glycemic variability (GV). Of course, the advantages of using glucose fluctuations (GF) has become easier due to the wide acceptance of the continuous glucose monitor (CGM) sensor device for diabetes patients in recent years.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Advances in Bioengineering and Biomedical Science Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
